Kim M, Suh G, Cullen G, Perez Rodriguez S, Dharmaraj T, Chang T
J Clin Invest. 2025; 135(5).
PMID: 40026251
PMC: 11870740.
DOI: 10.1172/JCI187996.
Lu C, He L, Guo Y, Wang T, Ye Y, Lin Z
Viruses. 2025; 17(1).
PMID: 39861840
PMC: 11769102.
DOI: 10.3390/v17010045.
Peng H, Chen I, Qimron U
Chem Rev. 2024; 125(2):933-971.
PMID: 39680919
PMC: 11758799.
DOI: 10.1021/acs.chemrev.4c00681.
Liu D, Siguenza N, Zarrinpar A, Ding Y
Eng Microbiol. 2024; 2(4):100048.
PMID: 39628703
PMC: 11610962.
DOI: 10.1016/j.engmic.2022.100048.
Cong X, Zhao S, Zhang Q, Liu S, Zhang Y, Yan F
Microorganisms. 2024; 12(11).
PMID: 39597735
PMC: 11596505.
DOI: 10.3390/microorganisms12112346.
Bacteriophages and their potential for treatment of metabolic diseases.
Deng Y, Jiang S, Duan H, Shao H, Duan Y
J Diabetes. 2024; 16(11):e70024.
PMID: 39582431
PMC: 11586638.
DOI: 10.1111/1753-0407.70024.
CRISPR/Cas9-Mediated Genome Editing of T4 Bacteriophage for High-Throughput Antimicrobial Susceptibility Testing.
He Y, Chen J
Anal Chem. 2024; 96(45):18301-18310.
PMID: 39474820
PMC: 11561875.
DOI: 10.1021/acs.analchem.4c05177.
A Critical Analysis of the Opportunities and Challenges of Phage Application in Seafood Quality Control.
Yan J, Guo Z, Xie J
Foods. 2024; 13(20).
PMID: 39456344
PMC: 11506950.
DOI: 10.3390/foods13203282.
Genetically engineered phages and engineered phage-derived enzymes to destroy biofilms of antibiotics resistance bacteria.
Eghbalpoor F, Gorji M, Alavigeh M, Moghadam M
Heliyon. 2024; 10(15):e35666.
PMID: 39170521
PMC: 11336853.
DOI: 10.1016/j.heliyon.2024.e35666.
Targeting microbial pathogenic mechanisms as a novel therapeutic strategy in IBD.
Miller P
Mol Med. 2024; 30(1):122.
PMID: 39135000
PMC: 11321147.
DOI: 10.1186/s10020-024-00840-9.
Engineered bacteriophages: A panacea against pathogenic and drug resistant bacteria.
Kakkar A, Kandwal G, Nayak T, Jaiswal L, Srivastava A, Gupta A
Heliyon. 2024; 10(14):e34333.
PMID: 39100447
PMC: 11295868.
DOI: 10.1016/j.heliyon.2024.e34333.
Gut microbes on the risk of advanced adenomas.
Jing Z, Zheng W, Jianwen S, Hong S, Xiaojian Y, Qiang W
BMC Microbiol. 2024; 24(1):264.
PMID: 39026166
PMC: 11256391.
DOI: 10.1186/s12866-024-03416-z.
CRISPR RNA-Guided Transposases Facilitate Dispensable Gene Study in Phage.
Liu Y, Liang Z, Yu S, Ye Y, Lin Z
Viruses. 2024; 16(3).
PMID: 38543787
PMC: 10974960.
DOI: 10.3390/v16030422.
Wall teichoic acid substitution with glucose governs phage susceptibility of .
Beck C, Krusche J, Notaro A, Walter A, Krankel L, Vollert A
mBio. 2024; 15(4):e0199023.
PMID: 38470054
PMC: 11005348.
DOI: 10.1128/mbio.01990-23.
Robust and Reproducible Protocol for Phage Genome "Rebooting" Using Transformation-Associated Recombination (TAR) Cloning into Yeast Centromeric Plasmid.
Baykov I, Kurchenko O, Mikhaylova E, Morozova V, Tikunova N
Methods Mol Biol. 2023; 2734:301-317.
PMID: 38066377
DOI: 10.1007/978-1-0716-3523-0_19.
Synthetic Biology to Engineer Bacteriophage Genomes.
Costa A, Azeredo J, Pires D
Methods Mol Biol. 2023; 2734:261-277.
PMID: 38066375
DOI: 10.1007/978-1-0716-3523-0_17.
Invasive uses a unique processive wall teichoic acid glycosyltransferase to evade immune recognition.
Guo Y, Du X, Krusche J, Beck C, Ali S, Walter A
Sci Adv. 2023; 9(47):eadj2641.
PMID: 38000019
PMC: 10672168.
DOI: 10.1126/sciadv.adj2641.
Overcoming Bacteriophage Resistance in Phage Therapy.
Laanto E
Methods Mol Biol. 2023; 2738:401-410.
PMID: 37966611
DOI: 10.1007/978-1-0716-3549-0_23.
Phage therapy: a revolutionary shift in the management of bacterial infections, pioneering new horizons in clinical practice, and reimagining the arsenal against microbial pathogens.
Karn S, Gangwar M, Kumar R, Bhartiya S, Nath G
Front Med (Lausanne). 2023; 10:1209782.
PMID: 37928478
PMC: 10620811.
DOI: 10.3389/fmed.2023.1209782.
Challenges of bacteriophages application in controlling bacterial plant diseases and how to overcome them.
Halawa E
J Genet Eng Biotechnol. 2023; 21(1):98.
PMID: 37815601
PMC: 10564689.
DOI: 10.1186/s43141-023-00549-y.